Kursprognose für Rain Enhancement Technologies Holdco Inc (RAIN)RAINRain Enhancement Technologies Holdco Inc

Alphio's RAIN stock price prediction model matches the current Rain Enhancement Technologies Holdco Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $0.50 (+0.15%). The 1-week path is $0.51 (+2.17%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

Rain Oncology Inc. is not a good buy right now due to its significant financial losses and poor market performance. The current price is $0.50, which is at the 0% position of its 52-week range, indicating it is at its lowest point. The company has a staggering year-to-date change of -89.94% and a forward P/E ratio of 0, reflecting no expected earnings growth. Additionally, the RSI is at 32.65, indicating that the stock is oversold, but this does not guarantee a rebound. The main risk is the company's ongoing net losses, with a net income of -$3,246,657 in Q2 2026, which raises concerns about its financial viability.

Rain Enhancement Technologies Holdco Inc (RAIN) last closed at $0.503, losing -6.68%. These facts feed the 1-day and 1-week RAIN price prediction above.